Bexel IRINA, iris diagnosis device developed by Suttong, achieved a revolutionary improvement in objectivity as well as accuracy with a computerized system based on many clinical studies. An automatic analysis allows an easy access to users with simple training, and these features are expected to make a great contribution to the development of Iridology.

STC Clincal Study Data
Dispensary examinations of groups of individuals are always done with the purpose to reveal the latent pathology early within the pre-clinical stage.
It is known that in some cases the signs in the iris occur long before the first clinical manifestations of the disease.
According to previous clinical studies performed by the Suttong Technical Corporation (STC) in Korea several important outcomes now exist.
Golden Standards: the Suttong Clinical Iridological Project
These studies were conducted at Aju University General Hospital located in Seoul, South Korea.
They ultimately succeeded to obtain an impressive government certification back in 1998. These were the outcomes:
1: Changes on the iris in the malignant pathology of the breast can be registered 3 to 5 years before the symptom complex really starts to occur.
2: In some types of lungs cancer, as early as 2 to 3 years before symptoms appear, the iris changes.
3. In people at risk for cardio-spastic reactions, iris signs are evident 0.5 to 2 years before symptoms appear.
4. In children, the functional weakness of the pancreas, gall bladder, and the risk of broncho-spastic reactions are well verified in the iris.
Moreover, a 10-year master prospective study was held in Korea complete with these outcomes:
All children and teenagers detected via the iris examination as belonging to the risk groups, systematically underwent preventive measures (diet, special gymnastics etc.)
They showed a significant percentage of decrease in manifestation of their genetic pathology when compared with the control data.
5. The study revealed the opportunity to analyze the state of an organism from the rare viewpoint of its integrity.
6. The study greatly promoted such features as completeness and reliability of the iris diagnosis.
As Joseph Deck himself once stated, irido-diagnostics are not limited by the thick clinical frameworks of one organ, but makes room for finding all the places of lowest resistance in the organism.
7. By revealing primary vs. secondary changes in the body, iridological examination is actively searching for the main primary component that violates the process of vital activity, and not for the secondary actors in the pathological process.
The Suttong Clinical Study Data
Table 2: Post-test Credibility of Iridology Clinical Study (%) obtained by applying the test to a number of 546 patients © 1997 Suttong Technical Corporation Clinical Study Results.
1) Credibility after Conducting the test to the number of 546 Patients(%)
|
Iris Change Level |
Digestive Organ |
Cardiovascular |
Urinary |
Hepatocystic Disease |
||
|
Mal-function |
Heart failure, Heart Risk Level |
Congenital Kidney defect, Nepharophelitis |
Acute Inflammation |
|||
|
Light |
16.4 |
14.0 |
31.1 |
19.5 |
15.4 |
32.0 |
|
Medium |
25.2 |
21.7 |
24.2 |
28.4 |
22.2 |
24.3 |
|
Heavy |
48.7 |
34.6 |
26.4 |
31.9 |
35.6 |
34.5 |
|
Total |
90.3 |
70.3 |
81.7 |
79.8 |
73.2 |
90.8 |
2) Clinical Test Results at Aju University
| Sensitivity | Specificity | Negative Predictive Value | Positive Predictive Value | |
| Accuracy, Reproducibility, Predictive Values (CT disease vs Non) | 87.5% | 87.5% | 77.8% | 93.3% |
| Accuracy, Reproducibility, Predictive Values (Cancer vs Non-cancer) | 71.4% | 94.1% | 83.3% | 88.9% |
| Accuracy, Reproducibility, Predictive Values (Normal vs Diseased) | 100.0% | 87.5% | 94.1% | 100.0% |
3) The Accepted Clinical results by Korean Government
|
% |
|
|
Digestive System |
90.2 |
|
Endocrine System |
86.4 |
|
Muscle/Skeletal System |
72.2 |
|
Nervous System |
79.9 |
|
Urogenital System |
85.7 |
|
Cardiovascular System |
75 |
|
Circulatory System |
81.6 |
|
Immune System |
54.2 |
|
Total |
78.2 |